|
|
- Biologicals - World Health Organization (WHO)
The beneficial impact of biologicals is as diverse as the types of products themselves: Vaccines are one of the most powerful and cost-effective ways to reduce the global burden of disease and are estimated to save 2–3 million lives every year
- Call for applications closed - 2025 Introductory course for biologics . . .
Proposed dates for the 2025 Introductory Course for Biologics Development and Manufacturing are: Monday, June 16, 2025 – Friday, June 27, 2025 (2 Weeks) Course Objectives After completing the course, participants will have basic and primary knowledge about various areas that are related to biologics manufacturing
- Guidelines for Biologicals - World Health Organization (WHO)
Recommendations to assure the quality, safety and efficacy of BCG vaccines, Annex 3, TRS No 979
- Introductory Course for Biologics Development and Manufacturing . . .
Low- and Middle-Income Countries (LMICs) face significant inequity in terms of access to vaccines and other biologics and are making efforts to establish biological manufacturing in their regions Establishing such manufacturing capacity, through bilateral technology transfer or through local R D efforts is often hindered by the lack of a trained workforce in biomanufacturing To address this
- WHO good manufacturing practices for biological products
93 Annex 2 WHO good manufacturing practices for biological products Replacement of Annex 1 of WHO Technical Report Series, No 822
- Health products policy and standards - World Health Organization (WHO)
INNs have been assigned to biological products since the early days of the INN Programme As well as many names for individual substances, animal insulin preparations were given an INN in Recommended list 3 in 1959
- Biologics Development and Manufacturing -introductory course available . . .
Low- and Middle-Income Countries (LMICs) face significant inequity in terms of access to vaccines and other biologics and are making efforts to establish biological manufacturing in their regions Establishing such manufacturing capacity, through bilateral technology transfer or through local R D efforts is frequently hampered by the lack of a workforce trained in biomanufacturing To address
- WHO adds LC16m8 mpox vaccine to Emergency Use Listing
LC16m8 is a vaccine developed and manufactured by KM Biologics in Japan The Technical Advisory Group (TAG) for EUL of vaccines convened to discuss the outcome of the LC16m8 vaccine review, including the product and programmatic suitability assessments
- Health products policy and standards - World Health Organization (WHO)
Our team provides authoritative guidance and standards on quality, safety and efficacy of health products and supports countries to formulate evidence-based policies and ensure good practice throughout the value chain
- Immunization, Vaccines and Biologicals - World Health Organization (WHO)
The Immunization, Vaccines and Biologicals department is responsible for targeting vaccine-preventable diseases, guiding immunization research and establishing immunization policy
|
|
英文每年常用名排名
2023 年排名
2022 年排名
2021 年排名
2020 年排名
2019 年排名
2018 年排名
2017 年排名
2016 年排名
2015 年排名
2014 年排名
2013 年排名
2012 年排名
2011 年排名
2010 年排名
2009 年排名
2008 年排名
2007 年排名
2006 年排名
2005 年排名
2004 年排名
2003 年排名
2002 年排名
2001 年排名
2000 年排名
英文名字起源
希伯來
希臘
條頓
印度
拉丁
拉丁語
古英語
英格蘭
阿拉伯
法國
蓋爾
英語
匈牙利
凱爾特
西班牙
居爾特
非洲
美洲土著
挪威
德國
威爾士
斯拉夫民族
古德語
愛爾蘭
波斯
古法語
盎格魯撒克遜
意大利
蓋爾語
未知
夏威夷
中古英語
梵語
蘇格蘭
俄羅斯
土耳其
捷克
希臘;拉丁
斯干那維亞
瑞典
波蘭
烏干達
拉丁;條頓
巴斯克語
亞拉姆
亞美尼亞
斯拉夫語
斯堪地納維亞
越南
荷蘭
|